リンパ浮腫治療器市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別（脚、腕）、用途別（家庭、病院、その他）、地域別＆競合別、2020-2030F

リンパ浮腫治療器の世界市場規模は2024年に5億6,221万米ドルとなり、予測期間では2030年までCAGR 5.18%で着実な成長が予測されています。

世界のリンパ浮腫治療器市場は、リンパ浮腫の有病率の上昇とその管理・治療に対する意識の高まりに牽引され、近年著しい成長と革新を遂げています。リンパ浮腫は、リンパ液の蓄積を特徴とする慢性疾患で、影響を受けた手足や体の一部に腫れや不快感をもたらします。リンパ浮腫は、手術、がん治療、先天性疾患など様々な要因によって生じる可能性があり、健康上の懸念事項として広く知られています。世界のリンパ浮腫治療器市場の主な促進要因の一つは、高齢化と治療の結果としてリンパ浮腫を発症する可能性のあるがん生存者の増加によるリンパ浮腫の発生率の開拓です。その結果、特殊な器具や機器を含む先進的で効果的な治療オプションに対する需要が急増しています。リンパ浮腫治療器具の技術的進歩が市場の成長をさらに促進しています。空気圧式圧迫装置、逐次勾配ポンプ、高度な圧迫衣などの技術革新は、リンパ浮腫患者の管理と生活の質を著しく向上させています。これらの機器は、腫れの軽減、リンパ循環の改善、リンパ浮腫に伴う痛みや不快感の緩和に役立っています。さらに、市場は、より洗練された使いやすいリンパ浮腫治療器具を導入することを目的とした研究開発活動への投資が増加しています。このような取り組みは、患者のコンプライアンスと快適性を高めることを目的としているため、これらの機器の採用を促進しています。

市場促進要因

リンパ浮腫の発生率の増加

主な市場課題

限られた認識と教育

主な市場動向

患者中心のケア

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のリンパ浮腫治療器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（脚、腕）
  • 用途別（家族、病院、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米のリンパ浮腫治療器市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のリンパ浮腫治療器市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のリンパ浮腫治療器市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のリンパ浮腫治療器市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのリンパ浮腫治療器市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Tactile Medical
• Essity（Bsn Medical Gmbh）
• 3M Company
• Cardinal Health
• Lohmann & Rauscher Gmbh & Co. Kg
• Airos Medical, Inc.
• Avet Pharmaceuticals Inc.
• Biocompression Systems
• Convatec Inc.
• Herantis Pharma Plc

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Lymphedema Treatment Instrument Market was valued at USD 562.21 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.18% through 2030. The Global Lymphedema Treatment Instrument Market has been witnessing significant growth and innovation in recent years, driven by a rising prevalence of lymphedema and an increased awareness of its management and treatment. Lymphedema is a chronic condition characterized by the accumulation of lymphatic fluid, leading to swelling and discomfort in affected limbs or body parts. It can result from various factors, including surgery, cancer treatment, or congenital disorders, making it a widespread health concern. One of the primary drivers of the global lymphedema treatment instrument market is the growing incidence of lymphedema due to an aging population and the rising number of cancer survivors who may develop lymphedema as a consequence of their treatment. As a result, there has been a surge in demand for advanced and effective treatment options, including specialized instruments and devices. Technological advancements in lymphedema treatment instruments have further fueled market growth. Innovations such as pneumatic compression devices, sequential gradient pumps, and advanced compression garments have significantly improved the management and quality of life for lymphedema patients. These instruments help in reducing swelling, improving lymphatic circulation, and alleviating pain and discomfort associated with the condition. Moreover, the market has witnessed increased investments in research and development activities aimed at introducing more sophisticated and user-friendly lymphedema treatment instruments. These efforts are aimed at enhancing patient compliance and comfort, thus driving the adoption of these devices.

Key Market Drivers

Rising Incidence of Lymphedema

The rising incidence of lymphedema is a key factor fueling the growth of the global lymphedema treatment instrument market, as it significantly increases demand for advanced, effective, and accessible treatment solutions. Lymphedema, a chronic medical condition characterized by persistent swelling, impacts an estimated 140 to 250 million individuals globally, representing a significant and growing healthcare burden worldwide. Increased incidence of obesity and chronic venous diseases. By 2050, 80% of the global elderly population will reside in low- and middle-income countries, reflecting a major demographic shift. The pace of population ageing is accelerating significantly compared to previous decades. Notably, in 2020, the number of individuals aged 60 and older surpassed the number of children under five for the first time. Between 2015 and 2050, the proportion of people aged 60+ is projected to nearly double from 12% to 22%, signaling a transformative trend with profound implications for healthcare systems, workforce dynamics, and consumer markets worldwide, especially in developed markets. As more individuals are diagnosed, healthcare systems and consumers are seeking reliable and efficient treatment instruments, such as pneumatic compression devices, laser therapy equipment, and lymphatic drainage systems. A larger, ongoing customer base supports consistent product demand and justifies market expansion efforts by manufacturers. With lymphedema being a long-term condition that often requires daily management, there is growing interest in non-invasive, user-friendly devices that can be used outside of clinical settings. This has driven innovation in portable compression pumps, wearable sleeves, and digital monitoring systems. Strong demand for home-use lymphedema treatment instruments is encouraging companies to invest in R&D for compact, connected, and cost-effective solutions.

Key Market Challenges

Limited Awareness and Education

A fundamental challenge facing the lymphedema treatment instrument market is the lack of awareness and education, both among healthcare professionals and the general public. Lymphedema remains underdiagnosed and undertreated, largely due to a lack of understanding about its causes, risk factors, and available treatment options. Healthcare providers often receive limited training in lymphedema management, leading to misdiagnosis or inadequate treatment. Moreover, patients themselves may not recognize the early signs of lymphedema, delaying their access to appropriate care and treatment instruments. Healthcare providers, including physicians, nurses, and therapists, may receive minimal training in lymphedema management during their education and professional development. This lack of education can result in misdiagnosis or suboptimal treatment, as healthcare professionals may not recognize the early signs or appropriate interventions for lymphedema. Consequently, patients are at risk of receiving inadequate care or being unaware of potential treatment instruments that could improve their condition.

Key Market Trends

Patient-Centric Care

A prominent trend in healthcare, including lymphedema management, is the shift toward patient-centric care. Healthcare providers are increasingly tailoring treatment plans to individual patient needs and preferences, including the use of treatment instruments. Patients are seeking personalized treatment options that align with their lifestyle and comfort. This trend has led to a greater demand for customized compression garments and patient-specific treatment plans. As healthcare systems evolve to prioritize patient-centered care, the lymphedema treatment instrument market is adapting to meet these demands, fostering a more patient-focused approach to lymphedema management. One of the key aspects of patient-centric care in the context of lymphedema treatment is the customization of care plans. Healthcare providers are increasingly recognizing the unique needs of each patient and tailoring treatment plans accordingly. This includes considering factors such as the severity of lymphedema, the patient's lifestyle, and their comfort levels with various treatment options, including treatment instruments.

Patients are seeking personalized treatment solutions that enhance their quality of life while effectively managing their condition. This trend has led to a greater demand for customized compression garments and patient-specific treatment plans that incorporate the use of treatment instruments. For example, patients may prefer specific types of pneumatic compression devices or sequential gradient pumps based on their individual needs and preferences .

Key Market Players

• Tactile Medical
• Essity (Bsn Medical Gmbh)
• 3M Company
• Cardinal Health
• Lohmann & Rauscher Gmbh & Co. Kg
• Airos Medical, Inc.
• Avet Pharmaceuticals Inc.
• Biocompression Systems
• Convatec Inc.
• Herantis Pharma Plc

Report Scope:

In this report, the Global Lymphedema Treatment Instrument Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lymphedema Treatment Instrument Market, By Type:

• Legs
• Arms

Lymphedema Treatment Instrument Market, By Application:

• Family
• Hospital
• Other

Lymphedema Treatment Instrument Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lymphedema Treatment Instrument Market.

Available Customizations:

Global Lymphedema Treatment Instrument market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lymphedema Treatment Instrument Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Legs, Arm)
  • 5.2.2. By Application (Family, Hospital, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Lymphedema Treatment Instrument Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Lymphedema Treatment Instrument Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Lymphedema Treatment Instrument Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Lymphedema Treatment Instrument Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Lymphedema Treatment Instrument Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Lymphedema Treatment Instrument Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Lymphedema Treatment Instrument Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Lymphedema Treatment Instrument Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Lymphedema Treatment Instrument Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Lymphedema Treatment Instrument Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Lymphedema Treatment Instrument Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Lymphedema Treatment Instrument Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Lymphedema Treatment Instrument Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Lymphedema Treatment Instrument Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Lymphedema Treatment Instrument Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Lymphedema Treatment Instrument Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Lymphedema Treatment Instrument Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Lymphedema Treatment Instrument Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Lymphedema Treatment Instrument Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Lymphedema Treatment Instrument Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Lymphedema Treatment Instrument Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Lymphedema Treatment Instrument Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Lymphedema Treatment Instrument Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Lymphedema Treatment Instrument Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Tactile Medical
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Essity (Bsn Medical Gmbh)
• 15.3. 3M Company
• 15.4. Cardinal Health
• 15.5. Lohmann & Rauscher Gmbh & Co. Kg
• 15.6. Airos Medical, Inc.
• 15.7. Avet Pharmaceuticals Inc.
• 15.8. Biocompression Systems
• 15.9. Convatec Inc.
• 15.10. Herantis Pharma Plc

16. Strategic Recommendations

17. About Us & Disclaimer